DiaSorin S.p.A.
DSRLF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $5 | $6 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $6 | $6 | $6 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2.1% | 1.2% | 7.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 65.9% | 65.2% | 66.3% | 65.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.9% | 31.5% | 30.8% | 31% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 15.5% | 16.6% | 15.2% | 15.7% |
| EPS Diluted | 0.88 | 0.96 | 0.87 | 0.84 |
| % Growth | -8.3% | 10.3% | 3.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |